| Frequency of EGFR mutations in 907 lung adenocarcioma patients of Indian ethnicity A Chougule, K Prabhash, V Noronha, A Joshi, A Thavamani, P Chandrani, ... PloS one 8 (10), e76164, 2013 | 118 | 2013 |
| EGFR Mutations in Indian Lung Cancer Patients: Clinical Correlation and Outcome to EGFR Targeted Therapy V Noronha, K Prabhash, A Thavamani, A Chougule, N Purandare, A Joshi, ... PLoS One 8 (4), e61561, 2013 | 82 | 2013 |
| Dysregulated serum response factor triggers formation of hepatocellular carcinoma S Ohrnberger, A Thavamani, A Braeuning, DB Lipka, M Kirilov, R Geffers, ... Hepatology 61 (3), 979-989, 2015 | 51 | 2015 |
| Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer A Choughule, R Sharma, V Trivedi, A Thavamani, V Noronha, A Joshi, ... British journal of cancer 111 (11), 2203-2204, 2014 | 41 | 2014 |
| The novel MKL target gene myoferlin modulates expansion and senescence of hepatocellular carcinoma C Hermanns, V Hampl, K Holzer, A Aigner, J Penkava, N Frank, DE Martin, ... Oncogene 36 (24), 3464-3476, 2017 | 33 | 2017 |
| Identification of Pparγ-modulated miRNA hubs that target the fibrotic tumor microenvironment I Winkler, C Bitter, S Winkler, D Weichenhan, A Thavamani, JG Hengstler, ... Proceedings of the National Academy of Sciences 117 (1), 454-463, 2020 | 30 | 2020 |
| PARP-inhibition reprograms macrophages toward an anti-tumor phenotype L Wang, D Wang, O Sonzogni, S Ke, Q Wang, A Thavamani, F Batalini, ... Cell reports 41 (2), 2022 | 16 | 2022 |
| Serum Response Factor (SRF) drives the transcriptional upregulation of the MDM4 oncogene in HCC R Pellegrino, A Thavamani, DF Calvisi, J Budczies, A Neumann, ... Cancers 13 (2), 199, 2021 | 9 | 2021 |
| Vps4A-mediated tumor suppression upon exosome modulation? I Akrap, A Thavamani, A Nordheim Annals of Translational Medicine 4 (9), 2016 | 5 | 2016 |
| Reciprocal antagonism of PIN1-APC/CCDH1 governs mitotic protein stability and cell cycle entry S Ke, F Dang, L Wang, JY Chen, MT Naik, W Li, A Thavamani, N Kim, ... Nature Communications 15 (1), 3220, 2024 | 1 | 2024 |
| Reciprocal inhibition of PIN1 and APC/CCDH1 controls timely G1/S transition and creates therapeutic vulnerability S Ke, F Dang, L Wang, JY Chen, MT Naik, A Thavamani, Y Liu, W Li, ... Research Square, 2023 | 1 | 2023 |
| The interaction of Serum Response Factor (SRF) and ETS domain transcription factors regulate the transcription of the MDM 4 oncogene in HCC R Pellegrino, A Thavamani, DF Calvisi, A Neumann, R Geffers, F Pinna, ... Zeitschrift für Gastroenterologie 57 (01), P4. 29, 2019 | 1 | 2019 |
| The interaction of Serum Response Factor (SRF) and ETS domain transcription factors regulate the transcription of the MDM 4 oncogene in HCC TL R Pellegrino, A Thavamani, DF Calvisi, A Neumann, R Geffers, F Pinna, P ... Zeitschrift für Gastroenterologie Full-text search Full-text search Author …, 2019 | | 2019 |
| Integrated multi-omic analysis of HCC formation in the SRF-VP16iHep mouse model A Thavamani Universität Tübingen, 2018 | | 2018 |
| Discovery of actionable alterations in lung adenocarcinoma P Chandrani, R Prasad, A Chougule, V Sethunath, J Aich, H Dhamne, ... EUROPEAN JOURNAL OF CANCER 54, S55-S56, 2016 | | 2016 |
| The novel MKL target gene MYOF (myoferlin) modulates expansion and senescence of hepatocellular carcinoma C Hermanns, V Hampl, A Aigner, S Singer, A Thavamani, A Nordheim, ... Naunyn-Schmiedebergs Archives of Pharmacology, S7-S7, 2016 | | 2016 |
| Dysregulated Serum Response Factor Triggers Formation of Hepatocellular Carcinoma (vol 61, pg 979, 2015) S Ohrnberger, A Thavamani, A Braeuning, DB Lipka, M Kirilov, R Geffers, ... HEPATOLOGY 61 (5), 1772-1772, 2015 | | 2015 |
| Serum response factor mediates Orai1 expression and store operated Ca2+ entry in murine hepatocellular carcinoma S Mia, M Sobuj, S Schmidt, S Honisch, A Thavamani, A Nordheim, ... ACTA PHYSIOLOGICA 213, 40-40, 2015 | | 2015 |
| Serum Reponse Factor (SRF) is a transcriptional activator of Mouse Double Minute 4 (MDM4) in hepatocellular carcinoma R Pellegrino, A Thavamani, R Geffers, P Schirmacher, A Nordheim, ... Zeitschrift für Gastroenterologie 53 (01), A4_46, 2015 | | 2015 |
| The Serum Reponse Factor (SRF) is involved in the transcriptional upregulation of the functional p53 inhibitor MDM 4 in hepatocellular carcinoma R Pellegrino, A Thavamani, R Geffers, P Schirmacher, A Nordheim, ... Zeitschrift für Gastroenterologie 52 (01), P_4_50, 2014 | | 2014 |
Amit DuttPrincipal Investigator/ Wellcome Trust DBT India Alliance Int Fellow, ACTREC, Tata Memorial CentreDirección de correo verificada de actrec.gov.in
